Sugi Predict

Sugi Predict / Compounds / SCHEMBL12430358

SCHEMBL12430358

SCHEMBL12430358

CC(C)(C)c1cc(-c2ccc(OCc3ccccc3)cc2)c(C#N)c(OS(=O)(=O)C(F)(F)F)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.48
▸ SQOR Q9Y6N5 2/20 0.47
▸ GRM2 Q14416 1/20 0.46
▸ GSTP1 P09211 2/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ AR P10275 1/20 0.39
▸ MAOB P27338 2/20 0.39
▸ MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12430356 0.87 SQOR (0.52) SQORGRM2GSTP1ALDH1A1HPGD
SCHEMBL2203268 0.87 PIM1 (0.48) PIM1SQORGRM2GSTP1ALDH1A1
SCHEMBL2816528 0.82 SQOR (0.55) SQORALDH1A1HPGDKDM4EMAPT
SCHEMBL12430366 0.80 PDE4A (0.48) SQORALDH1A1HPGDKDM4EMAPT
SCHEMBL14340812 0.80 SQOR (0.53) SQORALDH1A1HPGDKDM4ELMNA
SCHEMBL2819227 0.80 SQOR (0.48) SQORALDH1A1HPGDMAPTLMNA
SCHEMBL2820135 0.79 MEN1 (0.52) SQORALDH1A1HPGDMAPTLMNA
SCHEMBL12430361 0.79 SQOR (0.51) SQORALDH1A1HPGDKDM4EKMT2A
SCHEMBL2816429 0.79 SQOR (0.51) SQORALDH1A1HPGDKDM4EMAPT
SCHEMBL2199288 0.78 SQOR (0.52) SQORALDH1A1HPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-7977325-B2 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2011-07-12 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents GENESYS CLOUD SERVICES, INC. 2009-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030010-A1 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents MAP4K2, ABL1, MAP4K3 PIM1 507/4885SQOR 1563/4885GRM2 1601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.